Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets close in 5 hours 56 minutes
NZX 50
11,814.00
-60.04
(-0.51%)
NZD/USD
0.5966
+0.0003
(+0.05%)
ALL ORDS
7,849.40
+17.50
(+0.22%)
OIL
79.16
+0.21
(+0.27%)
GOLD
2,313.20
+3.60
(+0.16%)
Immunovant, Inc. (IMVT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.78
+0.26
(+0.91%)
At close: 04:00PM EDT
28.78
0.00
(0.00%)
After hours:
04:01PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
0
0
0
0
Operating expenses
Research development
198,709
160,257
101,808
68,604
Selling general and administrative
54,880
48,019
54,225
39,513
Total operating expenses
253,589
208,276
156,033
108,117
Operating income or loss
-253,589
-208,276
-156,033
-108,117
Interest expense
-
-
-
0
Total other income/expenses net
-10,565
-10,253
-781
328
Income before tax
-244,105
-210,951
-156,814
-107,789
Income tax expense
-656
9
-84
-358
Income from continuing operations
-243,449
-210,960
-156,730
-107,431
Net income
-243,449
-210,960
-156,730
-107,431
Net income available to common shareholders
-243,449
-210,960
-156,730
-107,431
Basic EPS
-1.96
-1.71
-1.43
-1.22
Diluted EPS
-1.96
-1.71
-1.43
-1.22
Basic average shares
130,197
123,075
109,679
87,757
Diluted average shares
130,197
123,075
109,679
87,757
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.